Purchase Short-Term Access

Review: Dabigatran increases MI and reduces mortality compared with warfarin, enoxaparin, or placebo

John Cairns, MD

Annals of Internal Medicine 2012;156:JC6-11. doi:10.7326/0003-4819-156-12-201206190-02011

Purchase Online access to this article for 24 hours

Annals of Internal Medicine

Forgot Your Password?

to gain full access to the content and tools.

Learn more about subscription options

Forgot your password?

Enter your username and email address. We'll send you a reminder to the email address on record.

Username* (Required)

Email Address* (Required)